Marketable Securities, Current of Pharma-Bio Serv, Inc. from 31 Oct 2010 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Pharma-Bio Serv, Inc. quarterly Marketable Securities, Current in USD history and change rate from 31 Oct 2010 to 31 Oct 2025.
  • Pharma-Bio Serv, Inc. Marketable Securities, Current for the quarter ending 31 Oct 2025 was $7,475,377, a 25% increase year-over-year.
Source SEC data
View on sec.gov
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

Pharma-Bio Serv, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,475,377 +$1,497,273 +25% 31 Oct 2025 10-K 29 Jan 2026 2025 FY
Q2 2025 $6,767,282 +$425,188 +6.7% 31 Jul 2025 10-Q 15 Sep 2025 2025 Q3
Q1 2025 $8,313,189 -$1,647,583 -17% 30 Apr 2025 10-Q 16 Jun 2025 2025 Q2
Q4 2024 $5,127,525 -$4,348,433 -46% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q1
Q3 2024 $5,978,104 +$1,446,940 +32% 31 Oct 2024 10-K 29 Jan 2026 2025 FY
Q2 2024 $6,342,094 -$5,372,502 -46% 31 Jul 2024 10-Q 16 Sep 2024 2024 Q3
Q1 2024 $9,960,772 +$4,456,962 +81% 30 Apr 2024 10-Q 14 Jun 2024 2024 Q2
Q4 2023 $9,475,958 +$1,228,465 +15% 31 Jan 2024 10-Q 18 Mar 2024 2024 Q1
Q3 2023 $4,531,164 +$4,531,164 31 Oct 2023 10-K 29 Jan 2025 2024 FY
Q2 2023 $11,714,596 31 Jul 2023 10-Q 14 Sep 2023 2023 Q3
Q1 2023 $5,503,810 30 Apr 2023 10-Q 14 Jun 2023 2023 Q2
Q4 2022 $8,247,493 31 Jan 2023 10-Q 17 Mar 2023 2023 Q1
Q3 2022 $0 31 Oct 2022 10-K 29 Jan 2024 2023 FY
Q3 2019 $0 -$44,475 -100% 31 Oct 2019 10-K 29 Jan 2020 2019 FY
Q3 2018 $44,475 +$17,875 +67% 31 Oct 2018 10-K 29 Jan 2020 2019 FY
Q2 2018 $38,713 +$7,363 +23% 31 Jul 2018 10-Q 14 Sep 2018 2018 Q3
Q1 2018 $36,219 +$15,913 +78% 30 Apr 2018 10-Q 14 Jun 2018 2018 Q2
Q4 2017 $25,056 +$3,087 +14% 31 Jan 2018 10-Q 19 Mar 2018 2018 Q1
Q3 2017 $26,600 +$6,317 +31% 31 Oct 2017 10-K 29 Jan 2019 2018 FY
Q2 2017 $31,350 +$3,681 +13% 31 Jul 2017 10-Q 14 Sep 2017 2017 Q3
Q1 2017 $20,306 -$2,019 -9% 30 Apr 2017 10-Q 14 Jun 2017 2017 Q2
Q4 2016 $21,969 -$4,611 -17% 31 Jan 2017 10-Q 17 Mar 2017 2017 Q1
Q3 2016 $20,283 -$13,146 -39% 31 Oct 2016 10-K 29 Jan 2018 2017 FY
Q2 2016 $27,669 -$6,769 -20% 31 Jul 2016 10-Q 14 Sep 2016 2016 Q3
Q1 2016 $22,325 -$25,685 -53% 30 Apr 2016 10-Q 14 Jun 2016 2016 Q2
Q4 2015 $26,580 -$39,200 -60% 31 Jan 2016 10-Q 16 Mar 2016 2016 Q1
Q3 2015 $33,429 -$34,448 -51% 31 Oct 2015 10-K 31 Jan 2017 2016 FY
Q2 2015 $34,438 -$32,545 -49% 31 Jul 2015 10-Q 14 Sep 2015 2015 Q3
Q1 2015 $48,010 -$20,400 -30% 30 Apr 2015 10-Q 15 Jun 2015 2015 Q2
Q4 2014 $65,780 +$1,656 +2.6% 31 Jan 2015 10-Q 17 Mar 2015 2015 Q1
Q3 2014 $67,877 -$3,383 -4.7% 31 Oct 2014 10-K 29 Jan 2016 2015 FY
Q2 2014 $66,983 -$28,017 -29% 31 Jul 2014 10-Q 15 Sep 2014 2014 Q3
Q1 2014 $68,410 -$26,590 -28% 30 Apr 2014 10-Q 16 Jun 2014 2014 Q2
Q4 2013 $64,124 -$30,876 -33% 31 Jan 2014 10-Q 17 Mar 2014 2014 Q1
Q3 2013 $71,260 -$23,740 -25% 31 Oct 2013 10-K 29 Jan 2015 2014 FY
Q2 2013 $95,000 $0 0% 31 Jul 2013 10-Q 16 Sep 2013 2013 Q3
Q1 2013 $95,000 $0 0% 30 Apr 2013 10-Q 14 Jun 2013 2013 Q2
Q4 2012 $95,000 $0 0% 31 Jan 2013 10-Q 18 Mar 2013 2013 Q1
Q3 2012 $95,000 $0 0% 31 Oct 2012 10-K 29 Jan 2014 2013 FY
Q2 2012 $95,000 $0 0% 31 Jul 2012 10-Q 14 Sep 2012 2012 Q3
Q1 2012 $95,000 30 Apr 2012 10-Q 14 Jun 2012 2012 Q2
Q4 2011 $95,000 31 Jan 2012 10-Q 16 Mar 2012 2012 Q1
Q3 2011 $95,000 $0 0% 31 Oct 2011 10-K 29 Jan 2013 2012 FY
Q2 2011 $95,000 31 Jul 2011 10-Q 14 Sep 2011 2011 Q3
Q3 2010 $95,000 31 Oct 2010 10-K/A 31 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.